Understanding Vitamin K Forms and Why It Matters for Safety
Vitamin K is a fat-soluble vitamin that exists in two primary natural forms: K1 (phylloquinone), found mainly in green leafy vegetables, and K2 (menaquinones), found in fermented foods and animal products. K2 itself has several subtypes; MK-4 and MK-7 are the most commonly supplemented. The vitamin K safety profile depends significantly on which form is being taken, in what dose, and — critically — whether the person is taking anticoagulant medications.
At maxfit.ee, vitamin K products are available in the vitamiin-k-et category, including NOW Vitamin K-2 (MK7) 100mcg 60 veg. caps., OstroVit Vitamin D3 + K2 90 tabs, OstroVit Vitamin K2 200 Natto MK-7 90tabs, and NOW Vitamin D-3 & K-2 120caps.
Common and Rare Side Effects
At standard supplemental doses, vitamin K is generally very well tolerated in people not taking anticoagulants. Phylloquinone (K1) has no established tolerable upper intake level in most regulatory frameworks — adverse effects from dietary or standard supplemental levels are not documented in healthy individuals.
Menaquinone K2 at supplemental doses (typically 45–360 µg/day of MK-7) is also considered very safe in healthy adults. Rare reported concerns at high doses include potential GI upset in sensitive individuals, but this is uncommon.
The most significant safety issue with vitamin K is not direct toxicity but its interaction with anticoagulant medications.
Upper Safe Limits
K1 has no formally established tolerable upper intake level because excess is not stored in meaningful quantities and is rapidly converted to a less active form. MK-7 (the long-chain K2 form used in most supplements) has a much longer half-life in the body than K1. No formal upper limit has been set for MK-7 either, but the long half-life means that consistent high-dose use warrants caution. Doses above 360 µg/day of MK-7 have not been studied extensively in long-term human trials.
Drug Interactions: The Warfarin Interaction
The most clinically important aspect of vitamin K safety is its direct antagonism with warfarin (and similar vitamin K antagonist anticoagulants). Warfarin works by blocking vitamin K-dependent clotting factor activation; any change in vitamin K intake directly affects the degree of anticoagulation. This is a two-way risk:
- Increasing K1 or K2 intake: reduces the anticoagulant effect, raising INR toward under-anticoagulation (clot risk).
- Suddenly stopping K supplementation: can swing INR toward over-anticoagulation (bleeding risk).
The clinical management principle is consistency: if you take vitamin K supplements regularly, maintain the same consistent dose and inform your prescriber. A regular, stable vitamin K intake is manageable in anticoagulated patients; erratic changes are the real problem. Schurgers et al. (2004) studied the effect of menaquinone (MK-7) on coagulation parameters and demonstrated that MK-7's longer half-life gives it a greater and more prolonged effect on vitamin K-dependent coagulation factors compared to K1, making the warfarin interaction with K2 supplementation particularly significant.
Who Should Avoid It Without Medical Supervision
- Anyone taking warfarin, acenocoumarol, or similar vitamin K antagonist anticoagulants should not start or stop vitamin K supplementation without consulting their prescriber. Stable, supervised use can be appropriate, but changes must be communicated.
- People with severe liver disease may have impaired vitamin K-dependent clotting factor synthesis — medical supervision required.
Quality Considerations
K2 as MK-7 is the form most intensively studied for bone and cardiovascular effects. When choosing a K2 supplement, look for products specifying MK-7 (not MK-4) and a clear stated dose in micrograms. Products combining vitamin D3 and K2 (MK-7) are popular because the two vitamins work together in calcium metabolism — vitamin D promotes intestinal calcium absorption while vitamin K directs calcium into bones rather than arterial walls.
FAQ
Do I need to take vitamin K with vitamin D?
Not required, but they work synergistically in calcium metabolism. High-dose vitamin D supplementation increases the production of vitamin K-dependent proteins that help direct calcium to the right places. Some researchers suggest that combining the two is preferable to very high vitamin D alone, though the clinical evidence for a mandatory combined protocol is not yet definitive.
Is K2 better than K1 for bones?
Most research on vitamin K and bone health has focused on K1 and MK-7 (K2). MK-7 has superior absorption and a longer half-life, and some observational and intervention studies associate higher MK-7 intake with better bone mineral density. The evidence is accumulating but not yet sufficient for definitive clinical recommendations.
Can I take vitamin K supplements if I'm healthy and not on blood thinners?
Yes, for most healthy adults at standard supplemental doses (45–200 µg/day of MK-7 or standard K1 intake), vitamin K supplementation has a very good safety profile. The primary consideration is avoiding large, erratic dose changes if you are, or may become, prescribed anticoagulants.
References
Schurgers, L. J., Shearer, M. J., Hamulyák, K., Stöcklin, E., & Vermeer, C. (2004). Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Blood, 104(9), 2682–2689. https://pubmed.ncbi.nlm.nih.gov/15231565/
Geleijnse, J. M., Vermeer, C., Grobbee, D. E., Schurgers, L. J., Knapen, M. H., van der Meer, I. M., Hofman, A., & Witteman, J. C. (2004). Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. Journal of Nutrition, 134(11), 3100–3105. https://pubmed.ncbi.nlm.nih.gov/15514282/
Knapen, M. H., Drummen, N. E., Smit, E., Vermeer, C., & Theuwissen, E. (2013). Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International, 24(9), 2499–2507. https://pubmed.ncbi.nlm.nih.gov/23525894/
